Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control

Retina

Volumn 27, Issue 8, 2007, Pages 1071-1073

  Pulido, Jose S ^a   Bakri, Sophie J ^a   Valyi Nagy, Tibor ^b   Shukla, Deepak ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alteplase; Eye; Intravitreal; Penetration; Retina; Rituxan; Rituximab; Tissue plasminogen activator

Indexed keywords

IMMUNOGLOBULIN G; PEROXIDASE; RITUXIMAB; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG PENETRATION; ENUCLEATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; RABBIT; RETINA; STORAGE; TEMPERATURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; ANTIRHEUMATIC AGENTS; IMMUNOENZYME TECHNIQUES; PLASMINOGEN ACTIVATORS; RABBITS; RETINA; TISSUE DISTRIBUTION;

EID: 37349105294     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31804ac032     Document Type: Article

References (5)

1. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739-746.
2. Jackson TL, Antcliff RJ, Hillenkamp J, et al. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 2003;44:2141-2146.
3. Bunt-Milam AH, Saari JC, Klock IB, et al. Zonulae adherents pore size in the external limiting membrane of the rabbit retina. Invest Ophthalmol Vis Sci 1985;26:1377-1380.
4. Mordenti J, Cuthbertson RA, Ferrara N, et al. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol 1999;27:536-544.
5. Shahar J, Avery RL, Heilweil G, et al. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 2006;26:262-269.